{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:19:57Z","timestamp":1790392797042,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":31,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1194\/jlr.ra120000856","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T21:45:23Z","timestamp":1598651123000},"page":"100031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver"],"prefix":"10.1016","volume":"62","author":[{"given":"Mingfeng","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preethi","family":"Chandrasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunxing","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3237-5803","authenticated-orcid":false,"given":"Matthew A.","family":"Mitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.RA120000856_bib1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1194\/jlr.RA120000856_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1194\/jlr.RA120000856_bib3","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1185\/03007995.2010.506375","article-title":"Population-based risk factors and resource utilization for HCC: US perspective","volume":"26","author":"Sanyal","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1194\/jlr.RA120000856_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jhep.2010.04.030","article-title":"Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes","volume":"53","author":"Targher","year":"2010","journal-title":"J.\u00a0Hepatol."},{"key":"10.1194\/jlr.RA120000856_bib5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ng.3855","article-title":"Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci","volume":"49","author":"Stender","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1194\/jlr.RA120000856_bib6","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1194\/jlr.RA120000856_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1194\/jlr.RA120000856_bib8","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/hep.23759","article-title":"The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease","volume":"52","author":"Rotman","year":"2010","journal-title":"Hepatology"},{"key":"10.1194\/jlr.RA120000856_bib9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/apt.13521","article-title":"I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders","volume":"43","author":"Xia","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1194\/jlr.RA120000856_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.27556","article-title":"Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity","volume":"61","author":"Sookoian","year":"2015","journal-title":"Hepatology"},{"key":"10.1194\/jlr.RA120000856_bib11","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1194\/jlr.RA120000856_bib12","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2016.07.045","article-title":"The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans","volume":"65","author":"Luukkonen","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1194\/jlr.RA120000856_bib13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/pr.2016.139","article-title":"Association of MBOAT7 gene variant with plasma ALT levels in children: The PANIC study","volume":"80","author":"Viitasalo","year":"2016","journal-title":"Pediatr. Res."},{"key":"10.1194\/jlr.RA120000856_bib14","doi-asserted-by":"crossref","first-page":"e49882","DOI":"10.7554\/eLife.49882","article-title":"Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease","volume":"8","author":"Helsley","year":"2019","journal-title":"Elife"},{"key":"10.1194\/jlr.RA120000856_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jsb.2019.04.006","article-title":"MBOAT7 is anchored to endomembranes by six transmembrane domains","volume":"206","author":"Caddeo","year":"2019","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1194\/jlr.RA120000856_bib16","doi-asserted-by":"crossref","first-page":"e06557","DOI":"10.7554\/eLife.06557","article-title":"Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion","volume":"4","author":"Rong","year":"2015","journal-title":"eLife"},{"key":"10.1194\/jlr.RA120000856_bib17","doi-asserted-by":"crossref","first-page":"30235","DOI":"10.1074\/jbc.M806194200","article-title":"Lysophospholipid acyltransferases and arachidonate recycling in human neutrophils","volume":"283","author":"Gij\u00f3n","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1194\/jlr.RA120000856_bib18","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1091\/mbc.e12-09-0673","article-title":"LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice","volume":"23","author":"Lee","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"10.1194\/jlr.RA120000856_bib19","doi-asserted-by":"crossref","first-page":"e58425","DOI":"10.1371\/journal.pone.0058425","article-title":"Lysophosphatidylinositol-acyltransferase-1 (LPIAT1) is required to maintain physiological levels of PtdIns and PtdInsP(2) in the mouse","volume":"8","author":"Anderson","year":"2013","journal-title":"PLoS One"},{"key":"10.1194\/jlr.RA120000856_bib20","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ajhg.2016.07.019","article-title":"Mutations in MBOAT7, encoding lysophosphatidylinositol acyltransferase I, lead to intellectual disability accompanied by epilepsy and autistic features","volume":"99","author":"Johansen","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1194\/jlr.RA120000856_bib21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cmet.2008.10.008","article-title":"Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: A delicate balance","volume":"8","author":"Radhakrishnan","year":"2008","journal-title":"Cell Metab."},{"key":"10.1194\/jlr.RA120000856_bib22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A\u00a0rapid method of total lipid\u00a0extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1194\/jlr.RA120000856_bib23","first-page":"E1146","article-title":"Mass isotopomer distribution analysis at eight years: Theoretical, analytic, and experimental considerations","volume":"276","author":"Hellerstein","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1194\/jlr.RA120000856_bib24","first-page":"E118","article-title":"Model equations for condensation biosynthesis using stable isotopes and radioisotopes","volume":"262","author":"Kelleher","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1194\/jlr.RA120000856_bib25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jacl.2017.06.005","article-title":"A\u00a0case of hypocholesterolemia and steatosis in a carrier of a PCSK9 loss-of-function mutation and polymorphisms predisposing to nonalcoholic fatty liver disease","volume":"11","author":"Di Filippo","year":"2017","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1194\/jlr.RA120000856_bib26","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1074\/jbc.M116.719955","article-title":"Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins","volume":"291","author":"Smagris","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1194\/jlr.RA120000856_bib27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cmet.2011.12.017","article-title":"The Scap\/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals","volume":"15","author":"Moon","year":"2012","journal-title":"Cell Metab."},{"key":"10.1194\/jlr.RA120000856_bib28","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.96.24.13656","article-title":"Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes","volume":"96","author":"Shimomura","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1194\/jlr.RA120000856_bib29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"10.1194\/jlr.RA120000856_bib30","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1101\/gad.891301","article-title":"SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation","volume":"15","author":"Matsuda","year":"2001","journal-title":"Genes Dev."},{"key":"10.1194\/jlr.RA120000856_bib31","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/hmg\/ddx159","article-title":"Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis","volume":"26","author":"Ehrhardt","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1194\/jlr.RA120000856_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"key":"10.1194\/jlr.RA120000856_bib33","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1194\/jlr.RA120000856_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/13543784.2020.1668374","article-title":"GS-0976 (Firsocostat): An investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)","volume":"29","author":"Alkhouri","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1194\/jlr.RA120000856_bib35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cmet.2017.07.009","article-title":"Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: A bedside to bench investigation","volume":"26","author":"Kim","year":"2017","journal-title":"Cell Metab."},{"key":"10.1194\/jlr.RA120000856_bib36","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1053\/j.gastro.2018.07.027","article-title":"GS-0976 reduces hepatic steatosis and fibrosis markers in patients with nonalcoholic fatty liver disease","volume":"155","author":"Loomba","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1194\/jlr.RA120000856_bib37","doi-asserted-by":"crossref","first-page":"11681","DOI":"10.1074\/jbc.M109.096107","article-title":"Polyunsaturated fatty acids selectively suppress sterol regulatory element-binding protein-1 through proteolytic processing and autoloop regulatory circuit","volume":"285","author":"Takeuchi","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1194\/jlr.RA120000856_bib38","doi-asserted-by":"crossref","first-page":"23577","DOI":"10.1074\/jbc.274.33.23577","article-title":"Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats","volume":"274","author":"Xu","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1194\/jlr.RA120000856_bib39","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1172\/JCI93616","article-title":"ER phospholipid composition modulates lipogenesis during feeding and in obesity","volume":"127","author":"Rong","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1194\/jlr.RA120000856_bib40","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1074\/jbc.M115.697011","article-title":"Small intestine but not liver lysophosphatidylcholine acyltransferase 3 (Lpcat3) deficiency has a dominant effect on plasma lipid metabolism","volume":"291","author":"Kabir","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1194\/jlr.RA120000856_bib41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbalip.2014.11.008","article-title":"Phosphoinositides: Key modulators of energy metabolism","volume":"1851","author":"Bridges","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1194\/jlr.RA120000856_bib42","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/ijms18030634","article-title":"Phosphoinositides, major actors in membrane trafficking and lipid signaling pathways","volume":"18","author":"De Craene","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1194\/jlr.RA120000856_bib43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0005-2736(92)90420-Q","article-title":"Freeze-fracture analysis of the effects of intermediates of the phosphatidylinositol cycle on fusion of rough endoplasmic reticulum membranes","volume":"1107","author":"Kan","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1194\/jlr.RA120000856_bib44","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.1074\/jbc.R117.000582","article-title":"Phospholipid subcellular localization and dynamics","volume":"293","author":"Yang","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1194\/jlr.RA120000856_bib45","doi-asserted-by":"crossref","first-page":"33501","DOI":"10.1074\/jbc.M303591200","article-title":"Mice lacking phosphatidylinositol transfer protein-alpha exhibit spinocerebellar degeneration, intestinal and hepatic steatosis, and hypoglycemia","volume":"278","author":"Alb","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1194\/jlr.RA120000856_bib46","doi-asserted-by":"crossref","first-page":"102658","DOI":"10.1016\/j.ebiom.2020.102658","article-title":"Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes","volume":"52","author":"Meroni","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1194\/jlr.RA120000856_bib47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/gutjnl-2020-320646","article-title":"LPIAT1\/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover","volume":"70","author":"Tanaka","year":"2021","journal-title":"Gut"}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227521000110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227521000110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.RA120000856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T09:54:26Z","timestamp":1645091666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227521000110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":47,"alternative-id":["S0022227521000110"],"URL":"https:\/\/doi.org\/10.1194\/jlr.ra120000856","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1194\/jlr.RA120000856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100031"}}